The active ingredient in Ozempic and Wegovy may help reduce the risk of kidney failure in those with type 2 diabetes and chronic kidney disease, according to a study published in the New England Journal of Medicine. Researchers across 28 different countries randomly assigned patients with type 2 diabetes and chronic kidney disease to receive...
Novavax says its COVID-19 shot is on track for full FDA approval after delay
- today, 11:14 AM
- abcnews.go.com
- 0

No comments